Iva Navrátilová

2.5k total citations
39 papers, 1.6k citations indexed

About

Iva Navrátilová is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Iva Navrátilová has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Organic Chemistry. Recurrent topics in Iva Navrátilová's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Receptor Mechanisms and Signaling (8 papers) and Glycosylation and Glycoproteins Research (7 papers). Iva Navrátilová is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Receptor Mechanisms and Signaling (8 papers) and Glycosylation and Glycoproteins Research (7 papers). Iva Navrátilová collaborates with scholars based in United Kingdom, United States and Czechia. Iva Navrátilová's co-authors include Andrew L. Hopkins, Petr Skládal, David G. Myszka, Daan M. F. van Aalten, Jérémy Besnard, Andrew T. Ferenbach, Joseph Sodroski, Marianna Dioszegi, Dario R. Alessi and Elton Zeqiraj and has published in prestigious journals such as The EMBO Journal, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Iva Navrátilová

39 papers receiving 1.5k citations

Peers

Countries citing papers authored by Iva Navrátilová

Since Specialization

Citations

This map shows the geographic impact of Iva Navrátilová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iva Navrátilová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iva Navrátilová more than expected).

Fields of papers citing papers by Iva Navrátilová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iva Navrátilová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iva Navrátilová. The network helps show where Iva Navrátilová may publish in the future.

Co-authorship network of co-authors of Iva Navrátilová

This figure shows the co-authorship network connecting the top 25 collaborators of Iva Navrátilová. A scholar is included among the top collaborators of Iva Navrátilová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iva Navrátilová. Iva Navrátilová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases 2024 ·European Journal of Medicinal Chemistry ·(unknown), F.J. Sorrell, James M. Bennett, Oleg Fedorov, (unknown), Paulo H. Godoi, (unknown), Sean W. Robinson, Iva Navrátilová, Jonathan M. Elkins, Simon E. Ward	4
2	Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2 2021 ·Cell chemical biology ·Benedict‐Tilman Berger, Marta Amaral, Daria B. Kokh, Ariane Nunes‐Alves, Djordje Müsil, Timo Heinrich, Martin Schröder, (unknown), Jing Wang, Iva Navrátilová, Joerg Bomke, Jonathan M. Elkins, Susanne Müller, Matthias Frech, Rebecca C. Wade, Stefan Knapp	50
3	Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates 2019 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Samuel T. Cahill, Jonathan M. Tyrrell, Iva Navrátilová, Karina Calvopiña, Sean W. Robinson, Christopher T. Lohans, M.A. McDonough, Ricky Cain, Colin W. G. Fishwick, Matthew B. Avison, Timothy R. Walsh, Christopher J. Schofield, Jürgen Brem	25
4	Inhibitors against Fungal Cell Wall Remodeling Enzymes 2017 ·ChemMedChem ·Ignacio Delso, (unknown), Fernando Gomollón‐Bel, J. Castro-López, Wenxia Fang, Iva Navrátilová, Daan M. F. van Aalten, Tomás Tejero, Pedro Merino, Ramón Hurtado‐Guerrero	10
5	Surface Plasmon Resonance Analysis of Seven-Transmembrane Receptors 2015 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown), Andrew L. Hopkins, Iva Navrátilová	21
6	Fragment screening by SPR and advanced application to GPCRs 2014 ·Progress in Biophysics and Molecular Biology ·(unknown), Andrew L. Hopkins, Iva Navrátilová	54
7	Structure of a bacterial putative acetyltransferase defines the fold of the human O -GlcNAcase C-terminal domain 2013 ·Open Biology ·Francesco Rao, Alexander W. Schüttelkopf, Helge C. Dorfmueller, Andrew T. Ferenbach, Iva Navrátilová, Daan M. F. van Aalten	47
8	O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis 2012 ·Nature Chemical Biology ·Marianne Schimpl, Xiaowei Zheng, Vladimir S. Borodkin, D.E. Blair, Andrew T. Ferenbach, Alexander W. Schüttelkopf, Iva Navrátilová, (unknown), Osama Albarbarawi, David A. Robinson, Megan A. Macnaughtan, Daan M. F. van Aalten	114
9	MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases 2011 ·The EMBO Journal ·B Filippi, Paola de los Heros, Youcef Mehellou, Iva Navrátilová, Robert Gourlay, Mária Deák, (unknown), Rachel Toth, Elton Zeqiraj, Dario R. Alessi	112
10	Mechanism of ubiquitylation by dimeric RING ligase RNF4 2011 ·Nature Structural & Molecular Biology ·Anna Plechanovová, Ellis Jaffray, S.A. McMahon, Kenneth A. Johnson, Iva Navrátilová, James H. Naismith, Ronald T. Hay	142
11	Biosensor-Based Approach to the Identification of Protein Kinase Ligands with Dual-Site Modes of Action 2011 ·SLAS DISCOVERY ·Iva Navrátilová, Graeme A. Macdonald, Colin Robinson, Samantha Jane Hughes, John P. Mathias, Chris Phillips, Andrew S. Cook	20
12	Substrate and product analogues as human O-GlcNAc transferase inhibitors 2010 ·Amino Acids ·Helge C. Dorfmueller, Vladimir S. Borodkin, D.E. Blair, Shalini Pathak, Iva Navrátilová, Daan M. F. van Aalten	57
13	Chapter 2 CCR5 Pharmacology Methodologies and Associated Applications 2009 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown), Sarah Able, Paul Griffin, (unknown), Ian James, Malcolm Macartney, (unknown), James E. Mills, Carolyn Napier, Iva Navrátilová, Manos Perros, (unknown), (unknown), Elna van der Ryst, Mike Westby, Patrick Dorr	13
14	ATP and MO25α Regulate the Conformational State of the STRADα Pseudokinase and Activation of the LKB1 Tumour Suppressor 2009 ·PLoS Biology ·Elton Zeqiraj, B Filippi, (unknown), Iva Navrátilová, Jérôme Boudeau, Mária Deák, Dario R. Alessi, Daan M. F. van Aalten	110
15	A biosensor-based approach toward purification and crystallization of G protein-coupled receptors 2006 ·Analytical Biochemistry ·Iva Navrátilová, Marie Pancera, Richard T. Wyatt, David G. Myszka	25
16	Measuring long association phases using Biacore 2005 ·Analytical Biochemistry ·Iva Navrátilová, (unknown), David G. Myszka	14
17	Solubilization, stabilization, and purification of chemokine receptors using biosensor technology 2005 ·Analytical Biochemistry ·Iva Navrátilová, Joseph Sodroski, David G. Myszka	79
18	Generation and characterization of single-chain antibody fragments specific against transmembrane envelope glycoprotein gp46 of maedi-visna virus 2003 ·Journal of Virological Methods ·Dalibor Blažek, V. Celer, Iva Navrátilová, Petr Skládal	21
19	The immunosensors for measurement of 2,4-dichlorophenoxyacetic acid based on electrochemical impedance spectroscopy 2003 ·Bioelectrochemistry ·Iva Navrátilová, Petr Skládal	80
20	Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus 2003 ·Folia Microbiologica ·V. Celer, Dalibor Blažek, Iva Navrátilová, Petr Skládal, Barbara Blacklaws, Raymond Bujdoso	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact